PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| uniQure NV | QURE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.2133 | -0.32% | 67.3167 | 67.73 | 66.149 | 67.50 | 67.53 | 09:59:33 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 67.31 | 67.84 | 0.53 | 0.78% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 343 | 62,965 | $ 67.15 | $ 4,228,364 | 636,102 | 30.2367 - 82.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:59:29 | 10 | $ 67.50 | USD |
uniQure NV Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.95B | 43.62M | $ -83.30M | -2.34 | - | 42.51M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
uniQure NV News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/17/2020 | 09:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 1/08/2020 | 13:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/20/2019 | 16:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/19/2019 | 07:00 | GlobeNewswire Inc. | uniQure Announces Publication of Preclinical Data for.. |
| 12/17/2019 | 16:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/17/2019 | 16:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/09/2019 | 18:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QURE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 66.66 | 70.985 | 64.0485 | 68.10 | 728,326 | 0.6567 | 0.99% |
| 1 Month | 71.93 | 76.6869 | 64.0485 | 70.48 | 531,058 | -4.61 | -6.41% |
| 3 Months | 49.48 | 76.6869 | 47.56 | 64.23 | 546,443 | 17.84 | 36.05% |
| 6 Months | 72.37 | 76.6869 | 36.20 | 56.13 | 559,871 | -5.05 | -6.98% |
| 1 Year | 31.44 | 82.49 | 30.2367 | 59.65 | 593,609 | 35.88 | 114.11% |
| 3 Years | 5.45 | 82.49 | 4.72 | 39.49 | 428,066 | 61.87 | 1,135.17% |
| 5 Years | 19.94 | 82.49 | 4.72 | 32.50 | 375,988 | 47.38 | 237.6% |
uniQure NV Description
| uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophilia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in Lexington Massachusetts and research and development facility in Amsterdam, the Netherlands, and Heidelberg, Germany. It is focused on the development of pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases. |
